ADC Therapeutics (ADCT) Return on Assets [ROA] (2021 - 2026)
ADC Therapeutics (ADCT) reported Return on Assets [ROA] of -51.55% for Q2 2026, up 7.33 percentage points from -58.88% a year earlier and up 3.50 percentage points from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2022, ADC Therapeutics posted Return on Assets [ROA] of -28.10%, up 12.55 percentage points from FY2021.
- By year, Return on Assets [ROA] came in at -40.65% in FY2021 (+34.97 pp) and -75.62% in FY2020.
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q3 2024.
- Year over year, Return on Assets [ROA] gained in three of the last six quarters, with an average year-over-year change of -2.72 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q1 2022 (a gain of 19.62 percentage points); the low point was Q1 2024 (a drop of 19.03 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.14% |
| 10 | ADC Therapeutics | 182.24 Mn | -763.95 Mn | 16.90 Mn | -51.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.55% |
| Mar 31, 2026 | -55.05% |
| Sep 30, 2025 | -58.86% |
| Jun 30, 2025 | -58.88% |
| Mar 31, 2025 | -55.26% |
| Sep 30, 2024 | -48.13% |
| Jun 30, 2024 | -52.04% |
| Mar 31, 2024 | -60.46% |
| Sep 30, 2023 | -36.65% |
| Jun 30, 2023 | -37.19% |
| Mar 31, 2023 | -41.43% |
| Dec 31, 2022 | -30.47% |
| Sep 30, 2022 | -31.56% |
| Jun 30, 2022 | -33.92% |
| Mar 31, 2022 | -32.53% |
| Dec 31, 2021 | -36.63% |
| Sep 30, 2021 | -45.64% |
| Jun 30, 2021 | -43.27% |
| Mar 31, 2021 | -52.15% |
API Access
ADC Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();